Michael Baumann
Staff scientist, National Institute on Drug Abuse (NIDA) Intramural Research Program
Data updated
Research Footprint
Michael Baumann appears in 5 tracked papers (2014–2026), most studied alongside MDMA, DMT and Psilocybin, across Medicinal Chemistry & Drug Development, Substance Use Disorders (SUD) and Tobacco/Nicotine Use Disorder (TUD).
Most-cited paper: Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes (97 citations).
Frequent co-authors: Ignacio Carrera, Matthew Baggot and Magí Farré.
Background & Research
Michael H. Baumann, Ph.D., is a staff scientist at the National Institute on Drug Abuse Intramural Research Program in Baltimore, Maryland. His research focuses on dopamine and serotonin systems and the molecular pharmacology of therapeutic and abused stimulant drugs, including new psychoactive substances. He established NIDA’s Designer Drug Research Unit, which studies the pharmacology and toxicology of emerging recreational drugs.
Key Impact
A leading pharmacologist in designer-drug and psychedelic-related neuropharmacology whose work has helped define the mechanisms of MDMA-like and other serotonergic psychoactive compounds.
Collaboration Network
6 collaborators· click a node to visit their profile
Full network →